Evidence map›Paper›PMID 24848004›Full record

ArticlePloS one2014

Screening of metagenomic and genomic libraries reveals three classes of bacterial enzymes that overcome the toxicity of acrylate.

Andrew R J Curson, Oliver J Burns, Sonja Voget, Rolf Daniel, Jonathan D Todd, Kathryn McInnis, Margaret Wexler, Andrew W B Johnston

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Metabolic engineering of low-pH-tolerant non-model yeast,Metabolic engineering communications · 2023
    Article
  3. A Review of the Biotechnological Production of Methacrylic Acid.Frontiers in bioengineering and biotechnology · 2020
    Review
  4. Recent Advances in Function-based Metagenomic Screening.Genomics, proteomics & bioinformatics · 2018
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Andrew R J CursonSchool of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
Oliver J BurnsSchool of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
Sonja VogetDepartment of Genomic and Applied Microbiology & Göttingen Genomics Laboratory, Institute of Microbiology and Genetics, Georg-August-University Göttingen, Göttingen, Germany.
Rolf DanielDepartment of Genomic and Applied Microbiology & Göttingen Genomics Laboratory, Institute of Microbiology and Genetics, Georg-August-University Göttingen, Göttingen, Germany.
Jonathan D ToddSchool of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
Kathryn McInnisSchool of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
Margaret WexlerSchool of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
Andrew W B JohnstonSchool of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
Norwich Research Park · GBUniversity of Göttingen · DEUniversity of East Anglia · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H002642/1Biotechnology and Biological Sciences Research Council NE/H008586/1
6 · The paper itself

Abstract

Acrylate is produced in significant quantities through the microbial cleavage of the highly abundant marine osmoprotectant dimethylsulfoniopropionate, an important process in the marine sulfur cycle. Acrylate can inhibit bacterial growth, likely through its conversion to the highly toxic molecule acrylyl-CoA. Previous work identified an acrylyl-CoA reductase, encoded by the gene acuI, as being important for conferring on bacteria the ability to grow in the presence of acrylate. However, some bacteria lack acuI, and, conversely, many bacteria that may not encounter acrylate in their regular environments do contain this gene. We therefore sought to identify new genes that might confer tolerance to acrylate. To do this, we used functional screening of metagenomic and genomic libraries to identify novel genes that corrected an E. coli mutant that was defective in acuI, and was therefore hyper-sensitive to acrylate. The metagenomic libraries yielded two types of genes that overcame this toxicity. The majority encoded enzymes resembling AcuI, but with significant sequence divergence among each other and previously ratified AcuI enzymes. One other metagenomic gene, arkA, had very close relatives in Bacillus and related bacteria, and is predicted to encode an enoyl-acyl carrier protein reductase, in the same family as FabK, which catalyses the final step in fatty-acid biosynthesis in some pathogenic Firmicute bacteria. A genomic library of Novosphingobium, a metabolically versatile alphaproteobacterium that lacks both acuI and arkA, yielded vutD and vutE, two genes that, together, conferred acrylate resistance. These encode sequential steps in the oxidative catabolism of valine in a pathway in which, significantly, methacrylyl-CoA is a toxic intermediate. These findings expand the range of bacteria for which the acuI gene encodes a functional acrylyl-CoA reductase, and also identify novel enzymes that can similarly function in conferring acrylate resistance, likely, again, through the removal of the toxic product acrylyl-CoA.

Indexed as

Genomic LibraryMetagenomicsAcrylatesBacterial ProteinsCarrier ProteinsCloning, MolecularDrug Resistance, BacterialEscherichia coliIntracellular Signaling Peptides and ProteinsMutationOxidoreductasesSinorhizobium frediiAcrylatesacrylic acidalanine-carrier protein, bacteriaBacterial ProteinsCarrier ProteinsIntracellular Signaling Peptides and ProteinsOxidoreductases

Identifiers

PMID24848004
PMCPMC4029986
OpenAlexW2114082183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.